Coral snake (micrurus fulvius) immune globulin antivenin (equine)

DB13883ApprovedProtein Based TherapiesAntivenins

Coral snake (micrurus fulvius) immune globulin antivenin (equine) is a mixture of antibodies used to treat venomous snake bites from Micrurus fulvius (North American Coral Snake). It is intravenously administered so that the antivenin binds to and neutralizes coral snake venom.

Mechanism
Curator reviewed
Primary indication
This particular antivenin is indicated only for the treatment of envenomation caused by bites from Eastern coral snakes (Micrurus fulvius fulvius) and Texas coral snakes (Micrurus fulvius tenere).Curator reviewed · 1 structured indication
First approval
United States, 1967
Also known as
Antivenin (micrurus fulvius) · Antivenin,micrurus fulvius · Coral snake (micrurus fulvius) antivenin (equine) · Coral snake (micrurus fulvius) immune antivenin (equine) · Coral snake antivenin

Resolves to

Clinical / RWD

What you can answer from here — as of April 02, 2025

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 1 country and 2 labellers
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Coral snake (micrurus fulvius) immune globulin antivenin (equine), and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account